Hengrui Pharma is developing obesity treatments, with Su Zhang leading non-oncology clinical development at the company.
1 report, 1 independent
Updated Jun 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Hengrui Pharma is developing obesity treatments, with Su Zhang leading non-oncology clinical development at the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Hengrui
Republic of China person CBDB = 91660
Nothing else this week.